TY - JOUR
T1 - Quantitation of harringtonine and homoharringtonine in serum by high-performance liquid chromatography
AU - Jui, Han
AU - Roboz, John
N1 - Funding Information:
The Er& author wishes to thank James F. Holland, Chairman of the Department of Neoplastic Diseases at MSSM for the opportunity to be a visiting scientist. The authors are grateful to DE H. Handschumacher and Mr_ L. Yu (Yale University School of Medicine) and Drs, A. Feinbek and T. Chou (Memorial Sloan-Kettering Institute) for their help in purifying the labeled harringtonine, Thanks ar& due to Mr, R. Suzuki and Dr. J. Greaves for technical help and suggestions. The work was partially supported by Grant CA-15936 from the National Cancer Institute, NIH, and by the T.J. Martell Memorial Foundation for Leukemia Research_
PY - 1982/12/10
Y1 - 1982/12/10
N2 - Harringtonine and homoharringtonine are naturally occurring alkaloids with demonstrated antineoplastic activity against certain types of leukemias in cell cultures, experimental animals, and initial clinical trials. Sample preparation consists of addition of the internal standard (one compound used as the internal standard for the other), solvent extraction with methylene chloride, washing with ammonium formate, and evaporation to dryness. The residue is dissolved in the mobile phase (40% methanol-60% 0.1 M ammonium formate) and an aliquot is chromatographed on μC18 reversed-phase column (flow-rate 1.5 ml/min). Peaks are detected with a spectrophotofluorimeter by monitoring the emission at 320 nm with excitation wavelength of 280 nm. Limit of detection is 10 ng/ml (20 nM) for both compounds; reproducible quantitation can be made to 30 ng/ml (60 nM).
AB - Harringtonine and homoharringtonine are naturally occurring alkaloids with demonstrated antineoplastic activity against certain types of leukemias in cell cultures, experimental animals, and initial clinical trials. Sample preparation consists of addition of the internal standard (one compound used as the internal standard for the other), solvent extraction with methylene chloride, washing with ammonium formate, and evaporation to dryness. The residue is dissolved in the mobile phase (40% methanol-60% 0.1 M ammonium formate) and an aliquot is chromatographed on μC18 reversed-phase column (flow-rate 1.5 ml/min). Peaks are detected with a spectrophotofluorimeter by monitoring the emission at 320 nm with excitation wavelength of 280 nm. Limit of detection is 10 ng/ml (20 nM) for both compounds; reproducible quantitation can be made to 30 ng/ml (60 nM).
UR - http://www.scopus.com/inward/record.url?scp=0020333638&partnerID=8YFLogxK
U2 - 10.1016/S0378-4347(00)81747-8
DO - 10.1016/S0378-4347(00)81747-8
M3 - Article
C2 - 7161333
AN - SCOPUS:0020333638
SN - 0378-4347
VL - 233
SP - 203
EP - 211
JO - Journal of Chromatography B: Biomedical Sciences and Applications
JF - Journal of Chromatography B: Biomedical Sciences and Applications
IS - 1
ER -